KELLI LOVELACE M.D. NPI 1629117528

NPI Details

Kelli Lovelace, M.D. is a dermatology in Tulsa, OK with 23 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. Kelli Lovelace, M.D. NPI is 1629117528. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Graduation Year:2003

The provider's business location address is:

2121 E 21ST ST
TULSA, OK
ZIP 74114-409
Phone: (918) 749-2261

The NPI 1629117528 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Destruction of skin growth, 15 or more growths (HCPCS:17111)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Biopsy of ear (HCPCS:69100)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• All potassium hydroxide (koh) preparations (HCPCS:Q0112)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:11310)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 2/6/2007 and was last updated on 5/16/2008.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.